Clinical trials
Completed Dyslipidemias trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 3 |
| 2006 | 10 |
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 3 |
| 2013 | 3 |
| 2019 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Takeda | 7 |
| Kowa Research Europe | 4 |
| Amarin Pharma Inc. | 2 |
| 89bio, Inc. | 1 |
| All India Institute of Medical Sciences | 1 |
| All India Institute of Medical Sciences, Bhubaneswar | 1 |
| Amgen | 1 |
| AstraZeneca | 1 |
| Centre for Chronic Disease Control, India | 1 |
| GlaxoSmithKline | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyslipidemias | 24 |
| Diabetes Mellitus, Type 2 | 9 |
| Glucose Metabolism Disorders | 8 |
| Diabetes Mellitus | 7 |
| Hypertriglyceridemia | 5 |
| Hypercholesterolemia | 4 |
| Hyperlipidemias | 3 |
| Metabolic Syndrome | 2 |
| Acute Coronary Syndrome | 1 |
| Angina Pectoris | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.